Glaxosmithkline | GSK - Market Capitalization

Stock Price
59.45
Daily Change
11.16 23.11%
Monthly
22.05%
Yearly
63.41%
Q1 Forecast
50.58

Glaxosmithkline reported GBP122.44B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 383.66B 20.17B Feb/2026
Amgen USD 184.41B 32.48B Feb/2026
AstraZeneca USD 233.07B 17.56B Sep/2025
Aurora Cannabis CAD 470.14M 146.16M Sep/2025
Bausch Health Companies USD 2.38B 979.68M Sep/2025
Bristol-Myers Squibb USD 118.91B 9.1B Feb/2026
Canopy Growth CAD 136.67M 644.68M Feb/2026
Corcept Therapeutics USD 8.76B 977M Sep/2025
Drreddys Laboratories INR 2.28B 9.41B Feb/2026
Eli Lilly USD 1.05T 36.63B Feb/2026
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
Merck USD 293.38B 83.74B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 147.57B 12.48B Feb/2026
Prestige Brands USD 3.26B 299M Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Supernus Pharmaceuticals USD 3B 1.24B Sep/2025
Takeda JPY 7.64T 774.9B Dec/2025
Teva Pharmaceutical Industries USD 36.42B 14.06B Dec/2025
Zoetis USD 64.85B 4.58B Sep/2025